Add to ORKGOn June 13th, the Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc., the case concerning human genes and patents. Myriad Genetics had identified two sections of the human genetic code that might indicate higher risk for certain types of cancer, and obtained patents on the isolated or removed versions of these two genes on the basis that Myriad invented a new chemical in the process of identifying and removing these genes from the body. The challengers claimed that Myriad Genetics had created nothing new, but rather the process is an examination of a substance found in nature whose attributes remain unchanged. Professor Gregory Dolin discusses the decision and its implications
The United States District Court for the Southern District of New York recently held in Association ...
Thesis: S.M., Massachusetts Institute of Technology, Department of Comparative Media Studies, 2015.C...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
On June 13th, the Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc....
On June 13th, the Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc....
On Monday, April 15, the Supreme Court heard oral argument in a patents case, Association for Molecu...
On Monday, April 15, the Supreme Court heard oral argument in a patents case, Association for Molecu...
On Monday, April 15, the Supreme Court heard oral argument in a patents case, Association for Molecu...
On June 13, the Supreme Court decided ACLU v. Myriad Technologies, one of the more important patent ...
On June 13, the Supreme Court decided ACLU v. Myriad Technologies, one of the more important patent ...
In Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court considered whethe...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the cas...
In June 2013, in Ass’n for Molecular Pathology et. al., v. Myriad Genetics, Inc., the Supreme Court ...
The United States District Court for the Southern District of New York recently held in Association ...
Thesis: S.M., Massachusetts Institute of Technology, Department of Comparative Media Studies, 2015.C...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...
On June 13th, the Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc....
On June 13th, the Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc....
On Monday, April 15, the Supreme Court heard oral argument in a patents case, Association for Molecu...
On Monday, April 15, the Supreme Court heard oral argument in a patents case, Association for Molecu...
On Monday, April 15, the Supreme Court heard oral argument in a patents case, Association for Molecu...
On June 13, the Supreme Court decided ACLU v. Myriad Technologies, one of the more important patent ...
On June 13, the Supreme Court decided ACLU v. Myriad Technologies, one of the more important patent ...
In Association for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court considered whethe...
This editorial examines the logical structure of the United States Supreme Court decision in Myriad ...
The US Supreme Court’s recent decision in Association for Molecular Pathology v. Myriad Genetics, In...
In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the cas...
In June 2013, in Ass’n for Molecular Pathology et. al., v. Myriad Genetics, Inc., the Supreme Court ...
The United States District Court for the Southern District of New York recently held in Association ...
Thesis: S.M., Massachusetts Institute of Technology, Department of Comparative Media Studies, 2015.C...
On April 15, 2013, the U.S. Supreme Court heard oral arguments in Association for Molecular Patholog...